SAFETY AND EFFICACY OF PROTROPIN GIVEN TO PATIENTS WITH GROWTH HORMONE DEFICIENCY

给予生长激素缺乏症患者的促肾上腺皮质激素的安全性和有效性

• 批准号: 3743603
• 负责人: BARBARA M LIPPE
• 金额: --
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3743603
• 关键词: child (0-11); child physical development; drug administration rate /duration; drug screening /evaluation; endocrine disorder; endocrine disorder chemotherapy; hormone therapy; human subject; human therapy evaluation; postnatal growth disorder; recombinant proteins; somatotropin

Biosynthetic human growth hormone is effective in promoting growth hormone deficient children. This study examines the safety and efficacy of two different schedules subcutaneously administered growth hormone to growth hormone deficient children.

生物合成的人类生长激素对促进生长有效 激素缺乏的孩子 本研究检查了 皮下注射生长激素， 生长激素缺乏的儿童。